DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kayexalate (Sodium Polystyrene Sulfonate) - Renal Impairment - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Impairment (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kayexalate (Sodium Polystyrene Sulfonate) where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-14

Patient: 53 year old male

Reactions: Leukocytoclastic Vasculitis, Renal Impairment, Sepsis, Anaemia, Dizziness, Hydrocephalus, Thrombocytopenia, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Administration route: Oral
    Start date: 2011-05-01

Keppra
    Administration route: Oral

Ramipril
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Repaglinide
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Prednisolone
    Administration route: Oral
    Start date: 2011-06-05
    End date: 2011-06-26

Calcium Carbonate
    Administration route: Oral

Amlodipine Besylate
    Administration route: Oral

Prednisolone
    Administration route: Oral
    Start date: 2011-06-30

Kayexalate
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Citalopram
    Dosage: 20
    Administration route: Oral

Renagel
    Administration route: Oral

Atorvastatin
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-24

Aranesp
    Dosage: 50mug

Other drugs received by patient: Solu-Medrol; Solu-Medrol



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine Besylate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Citalopram Base
    Dosage: unk
    Administration route: Oral

Kayexalate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Prednisolone
    Dosage: unk
    Start date: 2011-06-30

Atorvastatin
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-24

Eupressyl
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Keppra
    Dosage: unk
    Administration route: Oral

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Other drugs received by patient: Fucidine CAP; Methylprednisolone; Solu-Medrol; Locoid



Possible Kayexalate side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-03

Patient:

Reactions: Renal Impairment, Anaemia, Sepsis, Hydrocephalus, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Eupressyl
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calciparine
    Dosage: 0.2 ml, sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Aranesp
    Dosage: 50 mcg, every 15 days
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: 15 g, 3x/w
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Citalopram Hydrobromide
    Dosage: 20 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Calcium Carbonate
    Dosage: 1 unk, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Renagel
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hyperphosphataemia

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Depakene
    Dosage: 500 mg/kg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-16



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-02

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atorvastatin
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-14

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Eupressyl
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-29

Keppra
    Dosage: unk
    Administration route: Oral

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Kayexalate
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Citalopram
    Dosage: unk
    Administration route: Oral

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Other drugs received by patient: Fucidine CAP; Locoid; Solu-Medrol



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Prednisolone
    Dosage: unk
    Start date: 2011-06-30

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Atorvastatin
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-24

Eupressyl
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Keppra
    Dosage: unk
    Administration route: Oral

Citalopram Base
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Solu-Medrol; Fucidine CAP; Methylprednisolone; Locoid



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-20

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atorvastatin Calcium
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-24

Eupressyl
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Prednisolone
    Dosage: unk
    Start date: 2011-06-30

Citalopram Base
    Dosage: unk
    Administration route: Oral

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03
    End date: 2011-06-26

Keppra
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Methylprednisolone; Solu-Medrol; Locoid; Fucidine CAP



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-20

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atorvastatin Calcium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-14

Eupressyl
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-29

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral

Keppra
    Dosage: unk
    Administration route: Oral

Kayexalate
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Citalopram
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Solu-Medrol; Fucidine CAP; Locoid



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-06

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-04
    End date: 2011-06-27

Kayexalate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03
    End date: 2011-06-26

Ramipril
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-04
    End date: 2011-06-14

Citalopram
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Keppra
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Atorvastatin Calcium
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-24

Eupressyl
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Other drugs received by patient: Methylprednisolone; Fucidine CAP; Locoid



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-06

Patient: 53 year old male

Reactions: Renal Impairment, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Calcium Carbonate
    Dosage: oral
    Administration route: Oral

Calciparine
    Dosage: subcutaneous
    Start date: 2011-07-08
    End date: 2011-08-08

Valproate Sodium
    Dosage: 1000 mg (1000 mg 1 in 1 d), oral
    Administration route: Oral
    Start date: 2011-07-16

Prednisone
    Dosage: 30 mg (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Start date: 2011-05-01

Citalopram Hydrobromide
    Dosage: oral
    Administration route: Oral

Renagel
    Dosage: 1 dosage form (1 dosage forms, 1 in 1 d), oral
    Administration route: Oral

Eupressyl (Urapidil) (30 Milligram)
    Dosage: 90 mg (90 mg, 1 in 1 d), oral
    Administration route: Oral
    Start date: 2011-05-29

Kayexalate
    Dosage: 6.4286 g (45 gm, 1 in 1 wk)
    Start date: 2011-06-03

Aranesp
    Dosage: 3.3333 microgram (100 mcg, 1 in 1 m)



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-03

Patient: 53 year old male

Reactions: Renal Impairment, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Eupressyl
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-29

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Keppra
    Dosage: unk
    Administration route: Oral

Atorvastatin Calcium
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-24

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Citalopram Hydrobromide
    Administration route: Oral

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Other drugs received by patient: Methylprednisolone



Possible Kayexalate side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-23

Patient: male

Reactions: Renal Impairment, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 1 g, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-16

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Renagel
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hyperphosphataemia

Aranesp
    Dosage: 50 mcg, every 15 days
    Indication: Product Used FOR Unknown Indication

Citalopram
    Dosage: 20 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: 15 g, 3x/w
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Eupressyl
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calciparine
    Dosage: 0.2 ml, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Calcium Carbonate
    Dosage: 1 unk, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-11-18

Patient: 53 year old male

Reactions: Renal Impairment, Anaemia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate
    Dosage: 6.4286 g (15 gm,3 in 1 wk)
    Start date: 2011-06-03

Calcium Carbonate
    Dosage: oral

Renagel
    Dosage: 1 d f (1 dosage forms,1 in 1 d),oral

Aranesp
    Dosage: 3.3333 mcg (50 mcg,1 in 15 d), subcutaneous

Citalopram Hydrobromide
    Dosage: 20 mg (20 mg, l in 1 d),oral
    Administration route: Oral

Eupressyl (Urapidil)
    Dosage: 90 mg (90 rug, 1 in 1 d),oral
    Administration route: Oral
    Start date: 2011-05-29

Prednisone
    Dosage: 1 df (1 dosage forms,1 in 1
    Start date: 2011-05-01

Valproate Sodium
    Dosage: 1 g (1 gm, 1 in 1 d) , oral
    Administration route: Oral
    Start date: 2011-07-16

Calciparine
    Dosage: subcutaneous
    Start date: 2011-07-08
    End date: 2011-08-08

Other drugs received by patient: Levetiracetam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017